Mar 20
Current report
8-K
Other events
SRTA · Strata Critical Medical, Inc. · Documents
$5.56
+0.30 (+5.70%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$491.43M
Shares
88.47M
Volume · Nov 6
1.35M
Avg daily vol (3M)
944.97K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2024
Mar 12
Current report
8-K
Financial results
Mar 12
Annual report
10-K
FY2023, ended Dec 31
Annual report for FY2023
Revenue $225.18M
▲ 54.1%
Net loss $56.08M
Diluted EPS -$0.76
2023
Nov 8
Current report
8-K
Financial results
Nov 8
Quarterly report
10-Q
FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $71.44M
▲ 56.3%
Net income $289K
Diluted EPS $0.00
Aug 9
Current report
8-K
Financial results
Aug 9
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $60.99M
▲ 71.2%
Net loss $12.23M
Diluted EPS -$0.17
May 11
Current report
8-K
Financial results
May 11
Current report
8-K
Events of May 9
Shareholder vote results
May 11
Quarterly report
10-Q
FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $45.27M
▲ 70.0%
Net loss $10.19M
Diluted EPS -$0.14
Mar 30
Proxy statement
DEF 14A
Meeting May 9, 2023
Proxy statement
Mar 30
Mar 30
Proxy statement
DEFA14A
Proxy statement
Mar 16
Annual report
10-K
Ended Dec 31
Annual report for the period ended Dec 31, 2022
Revenue $146.12M
Net loss $27.26M
Diluted EPS -$0.38
Mar 14
Current report
8-K
Financial results
Feb 28
Current report
8-K
Events of Feb 27
Other events
Feb 13
Current report
8-K
Events of Feb 8
Other events
Jan 10
Current report
8-K
Other events
2022
Nov 10
Quarterly report
10-Q
FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $45.72M
▲ 125.1%
Net loss $9.25M
Diluted EPS -$0.13
Nov 9
Current report
8-K
Financial results
Sep 7
Current report
8-K
Events of Sep 1
Other events
Aug 9
Current report
8-K
Financial results
Aug 9
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $35.63M
▲ 175.1%
Net income $8.41M
Diluted EPS $0.10
May 19
Current report
8-K
Entered into a material agreement, Regulation FD disclosure
May 10
Current report
8-K
Financial results
May 10
Quarterly report
10-Q
FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $26.63M
▲ 187.2%
Net loss $11.01M
Diluted EPS -$0.16
May 6
Current report
8-K
Events of May 4
Shareholder vote results
Mar 22
Proxy statement
DEF 14A
Meeting May 4, 2022
Proxy statement
Mar 22
Proxy statement
DEFA14A
Proxy statement
Feb 10
Current report
8-K
Financial results
Feb 2
Current report
8-K
Events of Feb 1
Charter or bylaw amendment, or fiscal year change
2021
Dec 20
Current report
8-K
Financial results
Dec 20
Annual report
10-K
Ended Sep 30
Annual report for the period ended Sep 30, 2021
Revenue $50.53M
▲ 115.6%
Net loss $40.05M
Diluted EPS -$0.93
Dec 2
Current report
8-K
Events of Nov 30
Entered into a material agreement, Regulation FD disclosure
Sep 24
Current report
8-K
Events of Sep 22
Director or officer change, or executive pay, Regulation FD disclosure, Other events
Sep 17
Current report
8-K
Regulation FD disclosure
Sep 9
Current report
8-K
Events of Sep 2
Entered into a material agreement, Regulation FD disclosure
Aug 16
Current report
8-K
Financial results
Aug 16
Quarterly report
10-Q
FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $12.95M
▲ 276.7%
Net loss $24.29M
May 28
Registration statement
S-1
Registration statement
May 24
May 18
Late filing notice
NT 10-Q
Late filing notice
May 17
Current report
8-K/A
Events of May 7
Completed an acquisition or sale of assets
May 17
Current report
8-K
Financial results, Other events
May 13
Current report
8-K
Events of May 7
Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Change to shareholders' rights, Change in control, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Change in shell company status
May 10
Current report
8-K
Regulation FD disclosure
May 7
May 7
Current report
8-K
Regulation FD disclosure
May 6
Current report
8-K
Events of May 5
Shareholder vote results, Regulation FD disclosure
Apr 28
Current report
8-K
Events of Apr 26
Earlier financial statements no longer reliable, Other events
Showing 51–100 of 113 documents
Key facts
CIK
1779128
CUSIP
092667104
13F (30d)
70 filings
55 filers
Visit website
Investor relations